These energy-based procedures, which involve inserting a radiofrequency-charged cannula under the skin to heat it from within, are performed directly following the lift or tuck, during the same surgery
SURMOUNT-1 data shows that tirzepatide at the 10mg dose begins to plateau around 24 months as well, though higher doses may extend the active weight loss window somewhat further
By employing a similar methodology in an early PD population on standard of care, PADOVA has the potential to confirm the validity and generalizability of TTE analysis as a primary endpoint
1,4,5 Conversely, diets rich in refined carbohydrates and processed foods may suppress this beneficial response
The exact mechanisms are still being studied, but the clinical benefit is clearly established in multiple large trials